Hashimoto N, Ichihashi T, Hirano K, Yamada H
Shionogi Research Laboratories, Shionogi & Co., Ltd., Osaka, Japan.
Pharm Res. 1990 Apr;7(4):364-9. doi: 10.1023/a:1015815321570.
The epimerization of moxalactam (LMOX) in frozen urine and plasma samples was studied during long-term storage. The R/S ratio at equilibrium [(R/S)eq] at -10 degrees C was similar in urine and in rat and human plasma ultrafiltrate but differed from that in water. The (R/S)eq values in human plasma and its ultrafiltrate differed slightly, while they were the same in rat plasma and in its ultrafiltrate. The difference for the human plasma and ultrafiltrate may result from differences in plasma protein binding between R- and S-epimers in the liquid region of the frozen plasma. The change of R/S ratio in frozen human plasma continued below the collapse temperature of LMOX aqueous solution, where the liquid region appeared still to exist as determined by NMR measurement. Consequently, the biological LMOX samples should be preserved at or below -70 degrees C to prevent changes in the R/S ratio.
研究了长期储存期间莫西拉坦(LMOX)在冷冻尿液和血浆样本中的差向异构化。在-10℃时,尿液、大鼠和人类血浆超滤液中的平衡R/S比[(R/S)eq]相似,但与水中的不同。人类血浆及其超滤液中的(R/S)eq值略有差异,而大鼠血浆及其超滤液中的(R/S)eq值相同。人类血浆和超滤液的差异可能是由于冷冻血浆液体区域中R-和S-差向异构体之间血浆蛋白结合的差异所致。冷冻人血浆中R/S比的变化在LMOX水溶液的塌陷温度以下仍在继续,通过核磁共振测量确定,此时液体区域似乎仍然存在。因此,生物LMOX样本应保存在-70℃或更低温度下,以防止R/S比发生变化。